ARTICLE | Clinical News
ZD0473: Update
September 10, 2001 7:00 AM UTC
AnorMed Inc. (TSE:AOM), Vancouver, B.C. AstraZeneca plc (AZN; LSE:AZN), London, U.K. Product: ZD0473 Business: Cancer Therapeutic category: Cytotoxic Target: DNA Description: Platinum-based therapeu...